News
Cognivue is proud to support Davos Alzheimer’s Collaborative and their global efforts to fight Alzheimer’s Disease
September 28, 2021
Geneva, 21 September 2021 – The Davos Alzheimer’s Collaborative (DAC) is a global multi-stakeholder partnership that is mobilizing the world against Alzheimer’s disease. DAC announced today it has successfully completed financing of its foundational phase and has launched…
Cognivue, Inc. Initiates Nationwide Clinical Study to Assess Post-COVID-19 Syndrome (Long Haul Syndrome)
July 8, 2021
ROCHESTER, N.Y., July 8, 2021—Neuroscience company Cognivue, Inc. today announced the initiation of COG-COVID19, an open-label, prospective, two-armed comparison clinical study to assess the impact of COVID-19 on cognitive function. Researchers from…
Study Published in Neurological Sciences and Neurosurgery Shows FDA-Cleared Technology as Having Superior Test-Retest Reliability; Affirms Use as Efficient, Easy-to-Use Alternative to Traditional Pencil-and-Paper Assessment Methods ROCHESTER, N.Y., June 25, 2021—Neuroscience company…
Cognivue, Inc. and the American Institute of Balance Announce Inaugural Thought Leader Summit
June 10, 2021
Cognivue, Inc. and the American Institute of Balance Announce Inaugural Thought Leader Summit June 25-26, 2021 Audiology and otolaryngology leaders will discuss the industry’s role as part of a standard of care…
Cognivue, Inc. Joins Milken Institute’s Alliance to Improve Dementia Care Steering Committee
June 9, 2021
Cognivue, Inc. Joins Milken Institute’s Alliance to Improve Dementia Care Steering Committee The Alliance seeks to transform and improve the complex health and long-term care systems for individuals at risk for and…
Cognivue, Inc. Hosts National Symposium Focused on Urgency to Transform Cognitive Health Assessment
May 19, 2021
ROCHESTER, N.Y., May 12, 2021—Neuroscience company Cognivue, Inc. recently conducted a virtual national symposium to better define and establish a cognitive health care continuum that serves a diverse and growing at-risk population….
Victor company plays role in world-wide study, seeking to improve Alzheimer’s detection
April 27, 2021
VICTOR, N.Y. (WROC)- April 27th, 2021: Top Stories
Cognivue to Participate in Major Clinical Study with Global Alzheimer’s Platform First FDA-cleared computerized test of cognitive function will be evaluated in the Bio-Hermes study; seeks to improve identification and screening…
Cognivue CMO Newsletter, Fall 2020
November 18, 2020
Dr. Fred Ma addresses the COVID-19 pandemic and the role of cognitive testing. Cognivue CMO Newsletter, Fall 2020
Cognivue, Inc. has named Fred Ma, MD, PhD, as it’s Chief Medical Officer and Senior Vice President, effective immediately. His nearly four-decade career spans global medical device and pharmaceutical development and commercialization,…